$0.496
-0.0012 (-0.241%)
At Close: Jul 31, 2026
Bank of New York Mellon Corp Purchases 28,982 Shares of Heron Therapeutics Inc (NASDAQ:HRTX)
08:36am, Monday, 13'th Apr 2020
Bank of New York Mellon Corp lifted its position in Heron Therapeutics Inc (NASDAQ:HRTX) by 8.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Those Who Purchased Heron Therapeutics (NASDAQ:HRTX) Shares A Year Ago Have A 42% Loss To Show For It
11:21am, Friday, 10'th Apr 2020
This week we saw the Heron Therapeutics, Inc. (NASDAQ:HRTX) share price climb by 24%. But that is minimal compensation...
Heron Therapeutics (NASDAQ:HRTX) Trading Up 2.6%
09:22am, Friday, 10'th Apr 2020
Shares of Heron Therapeutics Inc (NASDAQ:HRTX) were up 2.6% during trading on Wednesday . The stock traded as high as $13.59 and last traded at $13.90, approximately 32,745 shares traded hands during
Heron Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
08:05pm, Thursday, 09'th Apr 2020
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most importan
2 Dirt-Cheap Growth Stocks to Buy Now
02:10pm, Thursday, 09'th Apr 2020
Heron Therapeutics and Intercept Pharmaceuticals are too cheap to ignore right now.
Heron Therapeutics Inc (NASDAQ:HRTX) Shares Bought by Bank of America Corp DE
08:36am, Thursday, 09'th Apr 2020
Bank of America Corp DE boosted its stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 29.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchan
Is Sally Beauty Holdings, Inc. (SBH) Going to Burn These Hedge Funds?
09:18pm, Tuesday, 07'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Hedge Funds Are Crazy About Insmed Incorporated (INSM)
07:33pm, Tuesday, 07'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Is Noah Holdings Limited (NOAH) A Good Stock To Buy?
07:33pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Should You Buy Terex Corporation (TEX)?
07:33pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Do Hedge Funds Love Heron Therapeutics Inc (HRTX)?
07:33pm, Tuesday, 07'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Baird Financial Group Inc. Buys New Holdings in Heron Therapeutics Inc (NASDAQ:HRTX)
08:44am, Tuesday, 07'th Apr 2020
Baird Financial Group Inc. bought a new stake in Heron Therapeutics Inc (NASDAQ:HRTX) in the 4th quarter, Holdings Channel.com reports. The firm bought 9,377 shares of the biotechnology company’s st
Man Group plc Purchases New Stake in Heron Therapeutics Inc (NASDAQ:HRTX)
10:32am, Monday, 06'th Apr 2020
Man Group plc purchased a new stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The instit
Despite Lacking Profits Heron Therapeutics (NASDAQ:HRTX) Seems To Be On Top Of Its Debt
01:57pm, Sunday, 05'th Apr 2020
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Heron Therapeutics Inc (NASDAQ:HRTX) Expected to Post Earnings of -$0.62 Per Share
10:12am, Friday, 03'rd Apr 2020
Brokerages forecast that Heron Therapeutics Inc (NASDAQ:HRTX) will report earnings of ($0.62) per share for the current quarter, according to Zacks Investment Research. Four analysts have issued estim
Sign In
Buy HRTX